Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571-583.

Publication Type:

Journal Article

Authors:

Nelson, P.K.; Mathers, B.M.; Cowie, B.; Hagan, H.; D. Des Jarlais; Horyniak, D.; Degenhardt, L.

Source:

Lancet, Volume 378, Issue 9791, p.571-583 (2011)

Keywords:

Africa, Antibodies, Asia, Australasia, Australia, China, complications, coverage, Drug Users, epidemiology, Europe, HCV, Health, hepatitis, Hepatitis B, Hepatitis B Virus, Hepatitis C, hepatitis C virus, Hiv, Humans, Infection, Latin America, Medline, methods, Middle East, New South Wales, North America, Prevalence, Public Health, Research, Research Support, Risk, Substance Abuse,Intravenous, systematic review, transmission

Notes:

PMC3285467

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/21802134

Export Citation:

RIS Format

Top